Chemotherapy, immunotherapy, and targeted oncology treatments cause potent side effects that can deteriorate rapidly if left unmonitored. OncoCare’s cancer symptom tracking app provides cancer patients with an intuitive, clinical-grade tool to record daily physiological and psychological symptoms from the comfort of home. Built upon the National Cancer Institute's Common Terminology Criteria for Adverse Events (CTCAE v5.0), the application translates complex medical toxicity grading into simple, patient-friendly questions. By establishing a direct, real-time feedback loop between patients and oncology nurses, OncoCare catches complications such as neutropenic fever, severe dehydration, or immune-related adverse events before they require intensive hospitalization. With automated trend visualizations and proactive clinical notifications, cancer care teams can intervene days before symptoms escalate into life-threatening emergencies or treatment delays.
Engineered for Oncology Precision
Advanced capabilities tailored for high-volume cancer care delivery
CTCAE v5.0 Standardized Grading
Converts patient inputs (frequency, severity, impact on daily activities) into standardized Grade 1 through Grade 4 toxicity scores familiar to clinical teams.
Chemo-Cycle Symptom Prediction
Anticipates symptoms based on current cycle day (e.g., peak nausea during Days 1–3, bone marrow nadir during Days 7–12) to offer preemptive guidance.
Red-Alert Emergency Escalation
Immediate triggers for critical clinical red flags (temperature >100.4°F, bleeding, intractable vomiting, sudden shortness of breath) sending emergency SMS and phone alerts.
Visual Longitudinal Trend Graphs
Patients and oncologists can review easy-to-read weekly trend graphs comparing symptom severity against chemotherapy infusion dates.
Vitals & Biometric Integration
Logs oral temperature, blood pressure, resting pulse, pulse oximetry (SpO2), and daily body weight to track fluid retention and cachexia.
Self-Care & Dietary Interventions
Delivers immediate, medically-validated home coping tips for mild (Grade 1) symptoms like dry mouth, mild nausea, diarrhea, and peripheral tingling.
Tailored for Every Oncology Stakeholder
Bridging communication, clinical safety, and care coordination
🏥 For Cancer Hospitals
Decreases emergency room readmission rates by 30%, frees up daycare beds through timely out-of-hospital interventions, and delivers robust digital quality metrics.
🩺 For Oncologists
Walks into consultations with complete visibility over the patient's nadir period rather than relying on retrospective memories that often omit crucial toxicity episodes.
🤝 For Patients & Caregivers
Restores confidence and control by taking the terrifying ambiguity out of chemotherapy side effects, providing reassurance on what is normal and clear guidance on when to seek help.
Frequently Asked Questions
Essential guidance for healthcare executives, clinicians, and patients
The Common Terminology Criteria for Adverse Events (CTCAE) is the international standard developed by the National Cancer Institute (NCI) for classifying treatment side effects. Using CTCAE allows OncoCare to communicate patient symptoms in the exact clinical terminology required by oncologists for dose adjustments and safety interventions.
The app employs strict multi-tier rule engines. Mild symptoms trigger automated home-care advice, while moderate symptoms alert the clinic's triage queue. Severe 'red flag' triggers immediately bypass queues, advising the patient to contact the hospital emergency desk while pushing high-priority notifications to the care team.
Yes. OncoCare contains specialized tracking modules for radiation dermatitis, dysphagia, proctitis, as well as immunotherapy-related adverse events (irAEs) like colitis, pneumonitis, and thyroid dysfunction.
Yes, OncoCare is available as a native iOS app, native Android app, and responsive progressive web application (PWA) that operates even in low-bandwidth network environments.